879 Mrv1909 11061917492D 17 18 0 0 1 0 999 V2000 2.6665 -1.4952 0.0000 S 0 3 2 0 0 0 0 0 0 0 0 0 4.5080 2.2494 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 3.7465 -0.7106 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.6409 -2.9164 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 0.5993 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 0.5993 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 1.8369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 3.0743 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -0.2256 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 2.4115 -0.7106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.4916 -1.4952 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 3.9764 -2.1627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 1.0119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 1.0119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 1.8369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 2.2494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1816 -2.1626 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 1 10 1 0 0 0 0 1 11 1 0 0 0 0 2 15 1 0 0 0 0 3 9 1 0 0 0 0 3 11 1 0 0 0 0 4 12 1 0 0 0 0 5 14 2 0 0 0 0 9 6 1 1 0 0 0 6 13 1 0 0 0 0 6 14 1 0 0 0 0 7 14 1 0 0 0 0 7 16 2 0 0 0 0 8 16 1 0 0 0 0 9 10 1 0 0 0 0 11 12 1 1 0 0 0 13 15 2 0 0 0 0 15 16 1 0 0 0 0 1 17 1 6 0 0 0 M CHG 2 1 1 17 -1 M END > DBMET02868 > drugbank > NC1=NC(=O)N(C=C1F)[C@@H]1C[S@@+]([O-])[C@H](CO)O1 > InChI=1S/C8H10FN3O4S/c9-4-1-12(8(14)11-7(4)10)5-3-17(15)6(2-13)16-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5-,6+,17+/m0/s1 > DMOMZPWPIDCLMB-WYDPKHCQSA-N > C8H10FN3O4S > 263.24 > 263.037605151 > 6 > 27 > 22.29524833907971 > 1 > 2 > 0 > 0 > (2R,3R,5S)-5-(4-amino-5-fluoro-2-oxo-1,2-dihydropyrimidin-1-yl)-2-(hydroxymethyl)-1,3-oxathiolan-3-ium-3-olate > -1.24 > -2.2708213906666663 > -1.11 > 0 > 2 > 0 > 18.68184151471832 > 14.010262300307126 > 1.4213889745737496 > 105.22 > 56.325500000000005 > 2 > 1 > 2.06e+01 g/l > (2R,3R,5S)-5-(4-amino-5-fluoro-2-oxopyrimidin-1-yl)-2-(hydroxymethyl)-1,3-oxathiolan-3-ium-3-olate > 0 > DBMET02868 > Emtricitabine 3'-sulfoxide (M-III) > TC80ZFJ2NZ $$$$